Core Scientific, Inc.
CORZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,315,005 | -$246,487 | -$2,146,318 | $47,312 |
| Dep. & Amort. | $120,121 | $96,445 | $226,093 | $33,362 |
| Deferred Tax | $0 | $0 | -$18,521 | $9,528 |
| Stock-Based Comp. | $51,924 | $58,892 | $182,894 | $38,937 |
| Change in WC | -$27,637 | $551,033 | $78,605 | -$49,516 |
| Other Non-Cash | $1,213,493 | -$394,769 | $1,882,434 | -$136,358 |
| Operating Cash Flow | $42,896 | $65,114 | $205,187 | -$56,735 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$94,961 | -$16,161 | -$601,657 | -$59,275 |
| Net Acquisitions | $0 | $0 | $10,850 | -$365,210 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $10,850 | $0 |
| Other Inv. Act. | -$231 | $13,165 | -$10,821 | $645 |
| Investing Cash Flow | -$95,192 | -$2,996 | -$590,778 | -$423,840 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $766,908 | -$40,991 | $117,740 | $613,701 |
| Stock Issued | $55,000 | $0 | $0 | $671,263 |
| Stock Repurch. | $0 | $0 | -$31,646 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,341 | -$3,658 | $220,059 | -$681,432 |
| Financing Cash Flow | $819,567 | -$44,649 | $306,153 | $603,532 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $767,271 | $17,469 | -$79,438 | $122,957 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $69,709 | $52,240 | $131,678 | $8,721 |
| End Cash | $836,980 | $69,709 | $52,240 | $131,678 |
| Free Cash Flow | -$52,065 | $48,953 | -$396,470 | -$116,010 |